Stocks and securities

Stocks and securities

X
X

Stocks and securities

Stocks and securities

X
X

Fabino Life Sciences Ltd


Loading
Fabino Life Sciences is a growing pharmaceutical company promoted by Atul Kumar Jain. The Company was incorporated as 'Fabino Life Sciences Private Limited' on October 27, 2011 with the Registrar of Companies, Delhi and Haryana. Subsequently, the Company got converted to Public Limited Company and the name of Company was changed to 'Fabino Life Sciences Limited' vide Special Resolution dated March 03, 2015. A fresh Certificate of Incorporation consequent to conversion was issued on March 21, 2015 by the Registrar of Companies, Delhi.

The Company operate in the business of manufacturing, marketing of pharmaceutical, allopathic, herbal, veterinary, and other wellness focused consumer products like, packing, trading, etc. The core business is marketing of pharmaceutical formulation & products in domestic market through its own distribution network and sales force under own brand name, getting Ayurvedic formulations manufactured through loan licensing facilities, packing, labeling etc. The Company export wellness and FMCG products like Coffee, Malt powder, Protein powder, Hair shampoo which are marketed by Company.

The Company operate a manufacturing plant at Sonipat, Haryana. The Company manufactures and pack products and market approximately 70+ products in the domestic market and have a portfolio of FMCG products for Overseas Markets. These products are being marketed under the respective trademarks and brands like 'Fabino' and 'Keepshine'. Fabino brand market mostly all pharmaceutical products including Tablets, Ointments Syrups etc for various medical treatments in allopathic and certain herbal range. Keepshine brand market Shampoo and Hair Maintenance products. Most of the Company product range is manufactured by third party manufacturers on made to order basis as per instructions or as per the manufacturer. These products are then marketed by Company. The products under this category are tablets, capsules, soft gelatin capsules, Gel, syrups, suspension, injections, Vitamin -C tablets, coffee, tea, etc.

The Company has obtained registration and patents for various products at becoming a strong intellectual property owning company in the future. Some of these products are manufactured by company in house at the processing centre in Sonipat Haryana, some of the products are manufactured at contract manufacturing facility in Haryana and other product range is manufactured by third party manufacturers on made to order basis as per instructions.

The marketing and distribution network in India and overseas comprises a specialized team of Marketing Executives, which enables the Company Promoters to market products to over 12 states across India. The Company also market products to various hospitals and medical institutions through their channel partners in different states, which constitute an important channel for the distribution of products. The domestic marketing infrastructure consists of dedicated teams & individuals associated with the Company directly and as channel partners, which formulate marketing and promotional strategies for their products. The Company currently supply in the Haryana, Delhi, parts of Punjab, Himachal Pradesh, Eastern Uttar Pradesh, Orissa , Jharkhand , parts of West Bengal, Andhra Pradesh and Nepal.

To provide a larger range of services, the Company has started a new division with manufacturing units for herbal and ayurvedic products. It undertakes third party herbal and food supplement product manufacturing orders. The Ayurvedic/ Herbal business operations are supported by loan licensing facilities which are approved by relevant authorities. The Company have been awarded a G.M.P Certification for following Good Manufacturing Practices of Ayurveda / Siddha/ Unnani drugs under 'Schedule T' of Drugs & Cosmetics Rules, 1945 in respect of various categories of Tablets, capsule, Oils, Syrups and Powder.

Fabino Company is an ISO 9001:2015 certified in recognition to quality standards and accredited with certifications pertaining to quality, health and safety standards. The quality policy is focused on fulfilling customer requirements through reliable products aimed at meeting all regulatory requirements and through continual improvement of quality management systems. The third party manufacturer products undergo a qualification process throughout the entire value chain to ensure that quality products are being provided to customers. The quality control programs involve subjecting the manufacturing processes and quality management systems to periodic reviews and observations for various periods. Further, the Company ensures that third party manufacturing facilities are accredited with necessary approvals and provide quality output for customers.

Sign up
for a free Demat account now!

Sign up for a free Demat account now!
Attention Investor
1. KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.          2. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.          3. Prevent Unauthorized Transactions in your demat account:Update your Mobile Number with your Depository Participant/ Stock Broker. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL / CDSL on the same day………. issued in the interest of investors.          4. For Stock Broking Transaction 'Prevent unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day...Issued in the interest of Investors.          5. Investors should be cautious on unsolicited emails and SMS advising to buy, sell or hold securities and trade only on the basis of informed decision. Investors are advised to invest after conducting appropriate analysis of respective companies and not to blindly follow unfounded rumours, tips etc. Further, you are also requested to share your knowledge or evidence of systemic wrongdoing, potential frauds or unethical behaviour through the anonymous portal facility provided on BSE & NSE website.           6. Email Id for reporting of cyber attacks: abm.cybersecurity@adityabirlacapital.com, Helpline number for reporting of cyber attacks : +91 8045860203.

Show Menu